Johannes Franciscus Diependaal
Direttore/Membro del Consiglio presso Insmed Innovation UK Ltd.
Profilo
Johannes Franciscus Diependaal currently works at Insmed Innovation UK Ltd., as Director from 2023.
Posizioni attive di Johannes Franciscus Diependaal
| Società | Posizione | Inizio |
|---|---|---|
Insmed Innovation UK Ltd.
 Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 30/06/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Johannes Franciscus Diependaal
